EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Urinary Biomarkers and Response to Treatment in Overactive Bladder (OAB): A Systematic Review and Meta‐Analysis

Thiago Khouri iD, Bruna Matos, Lukas Salles iD, Lucas Mira Gon, Cássio Riccetto

Neurourology and Urodynamics · 2026-11 · 45 (8) · 1678-1686

DOI: 10.1002/nau.70350 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Neurourology and Urodynamics, online erschienen am 19.06.2026. Verfasst von Thiago Khouri und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, São Paulo, Brazil. Hauptthemen laut MEDLINE: Urinary Bladder, Overactive, Nerve Growth Factor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Overactive bladder (OAB) is a prevalent symptom‐based syndrome lacking objective diagnostic tests. Urinary biomarkers, particularly nerve growth factor (NGF), have emerged as potential non‐invasive tool for diagnosis and treatment monitoring.

Objectives

To systematically review and meta‐analyze the association between urinary biomarker with treatment response and symptom score changes in adults with OAB.

Methods

Prospective clinical studies relating urinary biomarkers to established OAB treatments were identified in eight databases up to May 2024, selected with predefined criteria, assessed with the Newcastle–Ottawa Scale (NOS), and synthesized as percentage mean changes; meta‐analysis was limited to NGF.

Results

Nine studies carried out NGF data and smaller subsets reported on other biomarkers, showing post‐treatment biomarker reductions in both responders and non‐responders, with greater decreases and significantly larger symptom score improvements in responders.

Conclusions

Evidence regarding the usefulness of urinary biomarkers in OAB patients is still heterogeneous and limited. Urinary NGF levels decrease during OAB treatment in accordance with symptoms questionnaires scores improvement suggesting that some urinary biomarkers may serve as a useful tool for monitoring treatment response in patients for whom symptom questionnaires cannot be administered or are considered unreliable, contributing in the differentiation of different disease phenotypes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder, OveractiveNerve Growth FactorHumansBiomarkersTreatment OutcomeMuscarinic Antagonists

Stichwörter der Autor:innen

meta‐analysisoveractive bladdersystematic reviewtreatment responseurinary biomarkers

Substanzen

BiomarkersNerve Growth FactorMuscarinic Antagonists

Autor:innen und Institutionen

  • Department of Urology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, São Paulo, Brazil.

ORCID-Profile: Thiago Khouri, Lukas Salles

Zitieren

APA

Khouri, T., Matos, B., Salles, L., Gon, L. M., & Riccetto, C. (2026). Urinary Biomarkers and Response to Treatment in Overactive Bladder (OAB): A Systematic Review and Meta‐Analysis. Neurourology and Urodynamics, 45(8), 1678-1686. https://doi.org/10.1002/nau.70350

Vancouver

Khouri T, Matos B, Salles L, Gon LM, Riccetto C. Urinary Biomarkers and Response to Treatment in Overactive Bladder (OAB): A Systematic Review and Meta‐Analysis. Neurourology and Urodynamics. 2026;45(8):1678-1686. doi:10.1002/nau.70350

BibTeX
@article{Khouri2026,
  author = {Khouri, Thiago and Matos, Bruna and Salles, Lukas and Gon, Lucas Mira and Riccetto, Cássio},
  title = {Urinary Biomarkers and Response to Treatment in Overactive Bladder (OAB): A Systematic Review and Meta‐Analysis},
  journal = {Neurourology and Urodynamics},
  year = {2026},
  volume = {45},
  number = {8},
  pages = {1678--1686},
  doi = {10.1002/nau.70350}
}
Kostenlos starten →